University Health Network - Technology Development and Commercialization

The University Health Network office of Technology Development & Commercialization works with inventors at UHN research labs and hospitals to drive the most promising discoveries forward to patient impact. UHN is Canada’s largest Research Hospital. Our three research institutes are home to approximately 530 principal investigators, as well as their staff and students, and our annual research expenditure currently exceeds CAD $250 million.

The three hospitals of the University Health Network –Toronto Western, Toronto General, and Princess Margaret –share a long and storied history of transforming healthcare in their local communities, across Canada and around the world. High-impact examples from UHN hospitals include the discovery of insulin, the use of radiation to treat cancer, the identification of stem cells, and more recently, advances in image-guided radiation therapy.

The mandate of the UHN office of Technology Development & Commercialization (TDC) is to facilitate the identification and development towards practical applications of research discoveries with new product potential. As such, our office is responsible for establishing effective partnership arrangements with the private sector for the purposes of both knowledge transfer and technology licensing.